PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FluoGuide announces head and neck cancer therapy results

The treatment is administered intravenously prior to surgery, lighting up the cancer during surgery. FluoGuide – a company that concentrates on precision cancer s...
Continue Reading →
News

BioSenic to deliver news on copper-arsenic trioxide combination

Immunological disorder therapy data to be shared at International Conference on Redox Medicine. BioSenic – a company focusing on serious autoimmune diseases and c...
Continue Reading →
News

Anoat Therapeutics receives cystic fibrosis funding boost

Vital financing will be used to develop novel therapies for conditions with high unmet medical needs. Anoat Therapeutics – a company focusing on therapies for cys...
Continue Reading →
News

Rosemont acquires Lucis Pharma to boost portfolio

The company will gain access to a considerable pipeline of liquid products covering various disease areas. Rosemont Pharmaceuticals has announced the acquisition ...
Continue Reading →
News

Glance In The Future: Explore Innovative Solutions At PHARMAP 2023

Presenting innovative solutions and contributing to the further development of ongoing pharmaceutical trends were the main directions of the Pharmaceutical Manufactu...
Continue Reading →
News

Nanoform and Celanese Demonstrate Enhanced Drug Delivery through the Power of Smaller Implants

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Celanese Corporation, a global specialty materials company, today provided an update ...
Continue Reading →
News

Invizius’ ‘angry blood’ research recruits 300th patient

525-patient trial intends to assess ‘complement activation’ during HD in patients with end-stage renal failure Invizius – a company focusing on second-generation ...
Continue Reading →
News

Valneva reveals chikungunya vaccine data

VLA1553 had a high seroresponse rate among participants 28 days after receiving a single administration. Valneva – a company focused on developing vaccines for gl...
Continue Reading →
News

Cardiff University begins a study of schizophrenia therapy

The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor. A new schizophrenia drug being developed by Cardiff Universi...
Continue Reading →
News

Janssen reveals data from erdafitinib study

Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma. The Janssen Pharmaceutical Companies of Johnson & ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026